The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). (Q38078661)
Jump to navigation
Jump to search
scientific article published on February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). |
scientific article published on February 2013 |
Statements
1 reference
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). (English)
1 reference
Jan N Basile
1 reference
1 February 2013
1 reference
1 reference
Identifiers
1 reference